Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

BUY
$35.68 - $44.71 $438,899 - $549,977
12,301 New
12,301 $507,000
Q2 2022

Aug 11, 2022

SELL
$46.84 - $59.75 $267,175 - $340,814
-5,704 Reduced 50.47%
5,598 $277,000
Q1 2022

May 16, 2022

BUY
$48.09 - $57.79 $1,683 - $2,022
35 Added 0.31%
11,302 $646,000
Q4 2021

Feb 11, 2022

BUY
$47.19 - $62.68 $90,982 - $120,847
1,928 Added 20.64%
11,267 $591,000
Q3 2021

Nov 12, 2021

SELL
$56.91 - $67.81 $38,983 - $46,449
-685 Reduced 6.83%
9,339 $570,000
Q2 2021

Aug 13, 2021

BUY
$64.02 - $71.72 $204,864 - $229,504
3,200 Added 46.89%
10,024 $679,000
Q1 2021

May 14, 2021

SELL
$53.26 - $68.08 $310,239 - $396,566
-5,825 Reduced 46.05%
6,824 $447,000
Q4 2020

Feb 12, 2021

BUY
$43.41 - $56.51 $239,406 - $311,652
5,515 Added 77.31%
12,649 $712,000
Q3 2020

Nov 12, 2020

SELL
$47.43 - $60.75 $117,009 - $149,870
-2,467 Reduced 25.7%
7,134 $352,000
Q2 2020

Aug 14, 2020

BUY
$43.51 - $66.59 $102,727 - $157,218
2,361 Added 32.61%
9,601 $534,000
Q1 2020

May 15, 2020

BUY
$32.82 - $81.13 $237,616 - $587,381
7,240 New
7,240 $367,000
Q3 2019

Nov 14, 2019

SELL
$55.78 - $68.08 $8.43 Million - $10.3 Million
-151,204 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$53.69 - $65.47 $3.72 Million - $4.53 Million
69,236 Added 84.47%
151,204 $8.85 Million
Q1 2019

May 15, 2019

SELL
$44.53 - $58.9 $138,755 - $183,532
-3,116 Reduced 3.66%
81,968 $4.66 Million
Q4 2018

Feb 13, 2019

BUY
$47.64 - $71.26 $3.72 Million - $5.57 Million
78,183 Added 1132.92%
85,084 $4.21 Million
Q3 2018

Nov 13, 2018

BUY
$52.03 - $71.41 $359,059 - $492,800
6,901 New
6,901 $490,000
Q1 2018

May 11, 2018

SELL
$46.03 - $61.28 $4.01 Million - $5.34 Million
-87,129 Closed
0 $0
Q4 2017

Feb 14, 2018

BUY
$50.58 - $60.79 $4.41 Million - $5.3 Million
87,129
87,129 $5.1 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Hsbc Holdings PLC Portfolio

Follow Hsbc Holdings PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hsbc Holdings PLC, based on Form 13F filings with the SEC.

News

Stay updated on Hsbc Holdings PLC with notifications on news.